ArticlePDF Available

Breast Reconstruction Post Mastectomy: Patient Satisfaction and Decision Making

Authors:

Abstract and Figures

Background: Although breast reconstruction has been shown to improve psychological, physical, and sexual well-being, Australia still has one of the lowest reconstruction rates among well-developed countries. This study explores both the quality-of-life benefits of reconstruction and the factors that influence patients' decisions of whether or not to undergo reconstruction. Methods: This retrospective cohort study (296 consecutive mastectomy patients from 2000 to 2010) uses an internationally validated questionnaire (BREAST-Q) to evaluate patients' satisfaction with or without breast reconstruction. In addition, we analyzed factors that influence patients' decisions of whether to undergo reconstruction. Results: Two hundred nineteen patients responded (74%) and of the 143 patients who elected to participate, 79 were in the "reconstruction group" and 64 in the "no-reconstruction group" post mastectomy. Patient demographics and cancer variables of the 2 groups were matched with the exception of age (reconstruction group 9.7 years younger: P < 0.01). The reconstruction group showed statistically significantly higher BREAST-Q scores with regard to satisfaction with the breast (P < 0.0001), psychological well-being (P = 0.0068), and sexual well-being (P = 0.0001). For the reconstruction group, the main reasons for undergoing reconstruction included improved self-image, more clothing choices, and the feeling of overcoming the cancer. One third of non-reconstructed patients still feared that reconstruction would mask cancer recurrence. Conclusion: Our study confirms the positive effects of breast reconstruction post mastectomy and identifies reasons that influence patients' decisions of whether to undergo reconstruction. Breast reconstruction should be seen as an integral part in the comprehensive care of women with breast cancer and an important health care priority in Australia.
Content may be subject to copyright.
Breast Reconstruction Post Mastectomy
Patient Satisfaction and Decision Making
Sally K. Ng, MBBS(Hons), DipSurgAnat,* Rowena M. Hare, BA, BSc, MBBS,Þ
Ronny J. Kuang, MBBS(Hons),ÞKatrina M. Smith, BAppSci, GradDipHealthAdmin,Þ
Belinda J. Brown, MBBS, FRACS,Þand David J. Hunter-Smith, MBBS(Hons), FRACS*þ
Background: Although breast reconstruction has been shown to improve
psychological, physical, and sexual well-being, Australia still has one of the
lowest reconstruction rates among well-developed countries. This study ex-
plores both the quality-of-life benefits of reconstruction and the factors that
inf luence patients’ decisions of whether or not to undergo reconstruction.
Methods: This retrospective cohort study (296 consecutive mastectomy pa-
tients from 2000 to 2010) uses an internationally validated questionnaire
(BREAST-Q) to evaluate patients’ satisfaction with or without breast recon-
struction. In addition, we analyzed factors that influence patients’decisions of
whether to undergo reconstruction.
Results: Two hundred nineteen patients responded (74%) and of the 143 pa-
tients who elected to participate, 79 were in the ‘‘reconstruction group’’ and 64
in the ‘‘no-reconstruction group’’ post mastectomy. Patient demographics and
cancer variables of the 2 groups were matched with the exception of age (re-
construction group 9.7 years younger: PG0.01). The reconstruction group
showed statistically significantly higher BREAST-Q scores with regard to
satisfaction with the breast (PG0.0001), psychological well-being (P=
0.0068), and sexual well-being (P= 0.0001). For the reconstruction group, the
main reasons for undergoing reconstruction included improved self-image,
more clothing choices, and the feeling of overcoming the cancer. One third of
non-reconstructed patients still feared that reconstruction would mask cancer
recurrence.
Conclusion: Our study confirms the positive effects of breast reconstruction
post mastectomy and identif ies reasons that influence patients’ decisions of
whether to undergo reconstruction. Breast reconstruction should be seen as an
integral part in the comprehensive care of women with breast cancer and an
important health care priority in Australia.
Key Words: breast neoplasm, mastectomy, patient satisfaction, reconstructive
surgical procedures
(Ann Plast Surg 2016;76: 640Y644)
Despite the widespread use of breast conservation therapy, many
patients with breast cancer still require mastectomy as their
surgical treatment option. Mastectomy is often used when breast
conservation surgery would significantly distort the breast shape and
contour, when the tumor is multifocal, or when most of the breast is
involved. Prophylactic mastectomies for patients with hereditary breast
cancer genes BRCA1 and BRACA2 are also becoming more mainstream
in Western societies because of the availability of genetic testing.
Breast reconstruction aims to recreate the breast mound after
mastectomy and is now an integral component in the management of
breast cancer patients. In 2002, the National Institute for Health Ex-
cellence recommended that ‘‘reconstruction should be available to all
women with breast cancer at the initial surgical operation’’.
1
Recon-
struction can be achieved using implants and/or autologous tissue and
can be performed immediately with the initial mastectomy or as a de-
layed procedure. As far back as 1995, the National Health and Medical
Research Council made similar recommendations regarding the need to
discuss breast reconstruction with eligible women before mastectomy.
2
There is a growing acceptance of the value of breast recon-
struction, with many studies attesting to the physical, psychological,
and sexuality benefits of reconstruction for women with breast
cancer.
3Y6
A systematic review of studies of patient satisfaction with
breast reconstruction concluded that patients were generally satisfied
with breast reconstruction.
7
In addition, the benefits in psychosocial
well-being and body image continue to manifest at least 2 years after
reconstruction.
8
However, many of the earlier studies were based on
simple survey instruments and interviews to ascertain patient satis-
faction. The general relevance of the published research from dif-
ferent countries, with variable experiences and expectations, may not
be extrapolated and applicable to the Australian population.
Currently, the Royal Australian College of Surgeons Breast
Audit does not collect data about the total number of breast re-
constructions performed in Australia. In addition, it does not contain
information about satisfaction or quality-of-life outcomes.
Australian reconstruction rates are lower than in other Western
countries. In 1999, Hill et al reported that 6% of women underwent
breast reconstruction.
2
The National Breast Cancer Centre statistics
in 2003 indicated reconstruction rates of 8%.
9
The latest study by
Wang et al, based on the National Breast Cancer Audit between 1999
and 2006, found that the proportion of women having reconstruction
post mastectomy was highly age dependent, with 27% of women
aged 40 or less, 20% of women between 41 and 50 years, 9.4% of
women between 51 and 70 years, and less than 1% in women above
70 years having reconstructions.
10
On the contrary, reconstruction
rates in the UK have been reported as high as 32% (21% immediate
and 11% delayed)
11
and recent U.S. data show immediate recon-
struction rates of 38%.
12
Reasons for the relatively low uptake rate of reconstruction in
Australia are unclear. Potential barriers have been identified by
Sandelin et al, which include limited services in rural regions, long
waiting times in the public system, high out-of-pocket cost in the
private sector, inadequate involvement of breast reconstructive sur-
geons, and lack of information for women about reconstruction.
13
This study’s primary aim is to use a validated assessment tool
to evaluate patients’ satisfaction and quality of life with or without
reconstruction post mastectomy based on an Australian cohort. The
secondary aim is to identify factors that inf luence patient’s decision
of whether or not to undertake reconstruction.
BREAST SURGERY
640 www.annalsplasticsurgery.com Annals of Plastic Surgery &Volume 76, Number 6, June 2016
Received January 26, 2014, and accepted for publication, after revision, March 27,
2014.
From the *Departments of Plastic and Reconstructive Surgery and Surgery, Penin-
sular Health, Victoria; and Peninsula and Gippsland Clinical Schools, Monash
University, Victoria, Australia.
The results have been presented at the RACS Victoria AnnualScientific Meeting 2012
and Australia Society of Plastic Surgeon Annual Registrar Conference 2013 and
Royal Australasian College of Surgeons Annual Scientific Congress 2014.
Conflicts of interest and sources of funding: none declared.
Reprints: David Hunter-Smith, MBBS(Hons), FRACS, Department of Surgery, PO
Box 52, Frankston, Victoria 3199, Australia. E-mail: dhuntersmith@mac.com.
Copyright *2014 Wolters Kluwer Health, Inc. All rights reserved.
ISSN: 0148-7043/16/7606-0640
DOI: 10.1097/SAP.0000000000000242
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
PATIENTS AND METHODS
This is a retrospective cohort study approved by the Peninsula
Health Human Research and Ethics Committee.
Assessment Tools
A validated patient-reported outcome instrument known as the
BREAST-Q was used to assess patients’ satisfaction and quality of
life (QOL) after mastectomy.
14
Two cohorts were analyzed: those
who had reconstruction and those who did not have reconstruction.
Each module of the BREAST-Q consists of a core of indepen-
dent scales assessing 3 quality-of-life domains (physical, psychosocial,
and sexual well-being) and 3 satisfaction domains (satisfaction with
breasts, outcome, and care).
Questionnaire responses are entered into Q score, a data-
analyzing program that converts raw scores into a summary score
between 0 and 100. A higher score means higher satisfaction or better
health-related quality of life.
It is acknowledged that the clinical meaning of the BREAST-
Q score is not yet defined; however, the interpretation of the clinical
significance of the Q score suggests that a mean change of 5 to 10 is
perceived as ‘‘little’’ change, 10 to 20 as ‘‘moderate’’ change, and
greater than 20 as ‘‘significant’’ change.
15
To date, the BREAST-Q
has been validated in multiple studies and proven to be highly reli-
able, valid, and responsive to differences in patient outcomes.
16,17
The second section of the questionnaire aimed to explore the
reasons why patients made the decision whether or not to have breast
reconstruction after mastectomy. Responses in this section were a
categorical ranking of (1) important, (2) not important, or (3) some-
what important.
Data Collection
Each patient completed a study-specific questionnaire that
included demographic details and components of BREAST-Q as
described. Two reminders were sent to those who did not respond to
the initial mail-out.
Data Analysis
Descriptive data was calculated for continuous variables (mean
and standard deviation) and categorical values (frequency).
All analyses were performed using the NCSS statistical soft-
ware package (Hinze J, 2009, NCSS; NCSS LLC, Kaysville, UT,
USA) with 2-tailed tests of significance and the significance level
set at Pless than 0.05.
Study Population
Two hundred ninety-six female patients who underwent ther-
apeutic or prophylactic mastectomies between January 2000 and
December 2010 were identified from both the Peninsula Health da-
tabase (125) and a senior author’s private practice database (171).
Males were excluded.
RESULTS
Two hundred nineteen responses were received, giving a re-
sponse rate of 74.0%. Of those, 69 patients declined participation and
7 were notified as deceased. The remaining 143 patients formed the
study population, all of whom signed informed consent and the study
questionnaire.
The mean age at diagnosis of the study population was 54.5 T
12.9 years. When a patient had 2 diagnoses, the earliest age of di-
agnosis was recorded.
The 143 patients were divided into 2 groups: the first com-
prising 79 women (55%) who had a mastectomy with no recon-
struction and the second comprising 64 women (45%) who had
immediate or delayed reconstruction post mastectomy.
In the non-reconstructed group, there were 47 public and 32
private patients (59% and 41%, respectively). In the mastectomy with
reconstruction group, there were 24 public and 40 private patients
(38% and 62% respectively).
Demographic variables of the 2 groups were matched for
marital status, number of children, education, country of birth, in-
surance status, and household income, with the exception of age, the
reconstruction group being 9.7 years younger than the non-
reconstructed group (PG0.01) (Table 1). The cancer type and
treatment received by patients in each group were also matched.
In the reconstruction group, 41 women (64%) had autologous
reconstruction, 16 women (25%) had implant/tissue expander, and
7 women (11%) had autologous with implant reconstruction. Thirty-
six women had immediate reconstruction (56%) and 28 women
(44%) had delayed reconstruction.
The overall scores for each BREAST-Q domain for the non-
reconstructed group and reconstruction group are listed in Table 2.
The reconstruction group reported a statistically significantly higher
Q score in the satisfaction with breast (PG0.0001), psychological
well-being (P= 0.0068), and sexual well-being (P= 0.0001) domain
by 19.4, 9.5, and 17.5 points, respectively. The Q score for other
domains (physical well-being and satisfaction with surgeon, medical
staff, and office staff ) did not differ by statistically significant
amounts between the 2 groups.
Further analysis of the Q score was performed within the re-
construction group to determine if there were any differences with
regard to the timing of the reconstruction (immediate vs. delayed)
and the type of reconstruction (implant vs. autologous vs. combina-
tion of both). There was no statistically signif icant difference in all
the domains within each subgroup.
For women who had reconstruction post mastectomy, a sig-
nificant portion of patients rated improved self-image (80.6%),
TABLE 1. Baseline Patient Variables for the Reconstructed and
Non-Reconstructed Group
Variable
Reconstructed
(n = 64)
Non-Reconstructed
(n = 79)
Mean age at diagnosis
mean TSD (range)
49.1 T9.8 (23Y75) 58.8 T13.6 (32Y93)
Marital status n (%)
Single 5 (7.8) 2 (2.5)
De facto 7 (10.9) 3 (3.8)
Married 40 (62.5) 51 (64.6)
Divorced 9 (14.1) 11 (13.9)
Widowed 3 (4.7) 12 (15.2)
Highest level of education n (%)
Primary 1 (1.6) 3 (3.8)
Some secondary 11 (17.2) 26 (32.9)
Completed secondary 13 (20.3) 22 (27.9)
Some additional 19 (26.7) 15 (18.9)
Undergraduate 7 (10.9) 6 (7.6)
Post graduate 13 (20.3) 7 (8.9)
Annual household income $ n (%)
G35,000 17 (26.6) 36 (45.6)
35Y55,000 10 (15.6) 15 (18.9)
55Y80,000 4 (6.2) 8 (10.1)
80Y110,000 10 (15.6) 6 (7.6)
110Y150,000 8 (12.5) 5 (6.3)
150Y200,000 6 (9.4) 4 (5.1)
Not answered 8 (12.5) 4 (5.1)
Annals of Plastic Surgery &Volume 76, Number 6, June 2016 Breast Reconstruction Post Mastectomy
*2014 Wolters Kluwer Health, Inc. All rights reserved. www.annalsplasticsurgery.com 641
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
convenience of not wearing prosthesis or clothing limitations
(78.7%), the association of overcoming cancer (76.7%), and im-
proving their relationship with others (60.0%) as the most important
reasons for their decision to undergo reconstruction (Fig. 1). Of in-
terest, 77.4% of these women indicated that they paid $8,000 to
$10,000 total out-of-pocket cost for their reconstructive surgery.
For women who did not have reconstruction, approximately
one third of the women indicated that the reasons why they did not
wish to undertake reconstruction was that they feared the possibility
of reconstruction masking cancer recurrence (29.1%) and risks with
additional surgery (36.7%). However, cost did not appear to be a
hindering factor, with 40.5% of women indicating it was not an im-
portant factor that inf luenced their decision. Over 30% of women in
this group indicated that they are exploring or would like to re-
explore the option of reconstruction after participating in our study.
DISCUSSION
There is limited literature that investigates patients’satisfaction
and outcomes of breast reconstruction in Australia. One of the first
outcome studies by Panjari et al reported no difference in body image
between women who had or had not undergone reconstruction.
18
However, a recent publication by Bell et al, which focused on the
assessment of psychological well-being, found that, by adjusting for
age, the reconstruction group showed a more favorable outcome for
the domains of general health and well-being.
19
One of the limita-
tions of this study was the use of generic assessment scales, which
are insensitive to the unique issues of breast reconstruction pa-
tients.
20
Our present study is one of the few to examine whether there
is a difference in quality of life and satisfaction outcome for women
who had undergone mastectomy with or without reconstruction,
using a psychometrically robust patient-reported outcome instrument
specifically designed to evaluate outcomes among women undergo-
ing different breast surgeries. In our patient population, response to
the BREAST-Q demonstrated a statistically significantly higher
overall satisfaction with breast reconstruction, psychological well-
being, and sexual well-being for the group of women who had re-
construction. The score differences between the groups (satisfaction
with breast 19.4, psychological well-being 9.5, and sexual well-being
17.5) are referred to as ‘‘moderate’’ change. The clinical meaning of
the BREAST-Q scores requires further definition.
17
However, it has
been suggested that the interpretation of the clinical significance
between the 2 groups for scores on a health-related quality of life
instrument could be based on whether the difference exceeds 0.5 of a
standard deviation.
21
In our study, the BREAST-Q domains that
showed statistically significantly higher scores had mean score dif-
ferences that were at least 0.5 of a standard deviation. Therefore, it is
appropriate to consider the changes in these domains to be clinically
significant.
Controversy remains over the ideal timing of reconstruction,
and the effect of adjuvant therapy needs to be considered. The
Cochrane review in 2011 on immediate versus delayed reconstruction
concluded that there was some, albeit unreliable, evidence that im-
mediate reconstruction, compared with delayed or no reconstruction,
reduced psychiatric morbidity 3 months postoperatively.
22
In terms
of the types of reconstruction, a number of authors have reported
that patients generally expressed preference for autologous recons-
truction.
23Y26
However, the rates of implant reconstruction have also
increased significantly in the United States because of the signif icant
rise in immediate reconstruction, and it is still a popular option for
some patients.
12
We have performed a subgroup analysis of Q scores com-
paring immediate versus delay reconstruction, as well as implant
versus autologous reconstruction. In our study sample, there was no
FIGURE 1.Reasons for undergoing reconstruction (% respondent).
TABLE 2. Breast Q Scoring
Breast Q Score (Mean TSD)
Domain
Reconstructed
(n = 64)
Non-Reconstructed
(n = 79) P
Satisfaction with breast 68.3 T19.9 48.9 T21.9 0.0001
Psychological well-being 73.7 T19.2 64.2 T21.2 0.0068
Physical well-being 73.0 T15.4 71.2 T19.4 0.5400
Sexual well-being 55.2 T21.9 37.7 T26.8 0.0001
Satisfaction with information 70.7 T20.9 Not assessed V
Satisfaction with surgeon 89.7 T17.8 87.4 T18.3 0.4600
Satisfaction with medical staff 89.7 T18.8 93.0 T15.2 0.2500
Satisfaction with office staff 91.7 T18.6 93.6 T13.4 0.4800
Ng et al Annals of Plastic Surgery &Volume 76, Number 6, June 2016
642 www.annalsplasticsurgery.com *2014 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
statistically significant difference in Q scores in all domains between
the subgroups. However, it is difficult to interpret these findings as
our sample sizes in each subgroup were relatively small compared to
current published studies.
Methodologically rigorous multicenter prospective studies are
still required to compare the best and most appropriate timing and
method of breast reconstruction post mastectomy. Before such evi-
dence becomes available, all relevant reconstructive options should
be discussed with equal weighting to suitable patients.
Hall et al conducted one of the early studies looking at the
effects of socioeconomic factors on the likelihood of women
choosing to undertake reconstruction post mastectomy. They found
that women who were younger, with less co-morbidities, non-
indigenous background, and private insurance were more likely to
opt for reconstruction. On the other hand, women in lower socio-
economic groups or those from rural areas were less likely to receive
reconstruction.
27
Bell et el reported similar findings, where women
who had reconstruction were shown to be younger, educated beyond
school level, lived in metropolitan areas, had private insurance, and
had no dependent children.
19
In our study, there were no statistically
significant differences on any of the demographic variables, with the
exception of age, between the non-reconstruction and reconstruction
group. Although our cohort would be representative of women living
in metropolitan and regional areas of the state, we have not included
women in rural and remote areas. The establishment of a central
database of all the reconstruction cases is essential to analyze the
incidences and trends of reconstruction across the state and nation.
The decision-making process about reconstruction is complex.
Two Australian studies looking at the determinants for reconstruction
found that a major reason for reconstruction is ‘‘to feel whole again’’,
and the elimination of the prostheses helps to restore lost femininity
and sexuality.
28,29
In our study, the main reasons for women to un-
dergo reconstruction included improved self-image, convenience of
not having to use a prosthesis or clothing limitations, an improvement
to their relationship, and the sense of overcoming cancer. Of interest,
although some women in the reconstruction group reported a high
out-of-pocket cost for their surgery, it was not a major reason why
women in the non-reconstruction group decided not to have recon-
struction. Other factors such as inter-current medical or social prob-
lems are likely to affect the decision-making process and each patient
is likely to have their unique reasons. Our role as surgeons is to un-
derstand the factors involved and actively engaged patients in the
decision-making process.
There are still misconceptions about breast reconstruction,
with 29.1% of patients in the non-reconstruction group fearing that
reconstruction may mask the detection of cancer recurrence. Many
retrospective studies have demonstrated that the use of post-
mastectomy reconstruction does not interfere with the ability to de-
tect local recurrence.
30Y32
The quality and availability of preoperative
information must therefore be improved to enable women to under-
stand the risk and impact of surgery.
Considering the positive effect of breast reconstruction high-
lighted in our study, it is important to ensure that breast reconstruc-
tion can be offered on a routine basis in Australia, in both the private
and public sectors and irrespective of geographical distance. Patients
should receive accurate information in a format and level of detail
that meets their individual needs. The oncological and reconstruc-
tive management for each patient should be discussed at a multi-
disciplinary meeting and documented in the treatment plan. If
patients wish to defer reconstruction to a later stage, they should be
given an opportunity to re-explore reconstruction when they are
ready. To ensure a consistent standard of service, it is fundamental to
establish a national audit to assess the provision of service and re-
construction outcomes using a well-validated assessment tool such
as BREAST-Q. The Q score can be used to benchmark care across
different institutes within the state and nationally. The information
generated from the national audit can subsequently beused to develop a
set of best-practice guidelines for all the health care providers involved
with the management of breast cancer and breast reconstruction.
CONCLUSION
This is one of the few Australian studies that used a well-
validated instrument to determine if there is a satisfaction differ-
ence between patients who did or did not have reconstruction post
mastectomy. The results confirm that women who have reconstruc-
tion have overall higher satisfaction with appearance of the breast, as
well as their psychological and sexual well-being.
This highlights the importance of reconstruction in the compre-
hensive care of women with breast cancer. We as clinicians should ensure
that appropriate resources are available to enable equitable access to
breast reconstruction post mastectomy. To this end, it is also important to
establish a comprehensive national database to assess provision ofservice
and outcome of care applicable to the Australian population.
REFERENCES
1. National Institute for Clinical Excellence (NICE). Guidance on cancer serv ices:
improving outcomes in breast cancerVmanual update. London: NICE, 2002.
Available from: http://www.nice.org.uk/nicemedia/pdf/Improving_outcomes_
breastcancer_manual.pdf
2. Hill D, Jamrozik K, White V, et al. Surgical Management of Breast Cancer in
Australian Women in 1995. Sydney: NHMRC National Breast Cancer Centre;
1999.
3. Wilkins EG, Cederna PS, Lowery JC, et al. Prospective analysis of psycho-
social outcomes in breast reconstruction: one year post-operative results from
the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg.
2000;106:1014Y1025.
4. Nano MT, Gill PG, Kollias J, et al. Psychological impact and cosmetic outcome
of surgical breast cancer strategies. ANZ J Surg. 2005;75:940Y947.
5. Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological as-
pects and patient satisfaction following breast conserving surgery, simple
mastectomy and breast reconstruction. Eur J Cancer. 2000;36:1938Y1943.
6. Neto MS, de Aguiar Menezes MV, Moreira JR, et al. Sexuality after breast
reconstruction post mastectomy. Aesthetic Plast Surg. 2013;37:643Y647.
7. Guyomard V, Leinster S, Wilkinson M. Systematic review of studies of pa-
tients’ satisfaction with breast reconstruction after mastectomy. Breast.
2007;16:547Y567.
8. Atisha D, Alderman AK, Lowery JC, et al. Prospective analysis of long-term
psychosocial outcomes in breast reconstruction: two-year postoperative re-
sults from the Michigan Breast Reconstruction Outcome Study. Ann Surg.
2008;247:1019Y1028.
9. Breast Cancer Network Australia (BCNA). Breast Reconstruction Project
Report. Melbourne: BCNA; 2011.
10. Wang J, Kollias J, Boult M, et al. Patterns of surgical treatment for women with
breast cancer in relation to age. Breast J. 2010;16:60Y65.
11. Jeevan R, Browne J,van der Meulen J et al. Fourth annual report of the National
Mastectomy and Breast Reconstruction Audit 2011. Leeds: The NHS Infor-
mation Centre 2011. Available form: http://www.hscic.gov.uk/catalogue/
PUB02731/clin-audi-supp-prog-mast-brea-reco-2011-rep1.pdf.
12. Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. breast
reconstruction: increasing implant rates. Plast Reconstr Surg. 2013;131:15Y23.
13. Sandelin KW, King E, Redman S. Breast reconstruction following mastectomy:
current status in Australia. ANZ J Surg. 2003;73:701Y706.
14. Pusic AL, Klassen AF, Scott AM, et al. Development of a new patient reported
outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg.
2009;124:345Y353.
15. Memorial Sloan-Kettering Cancer Centre. Breast Q User Manual. New York:
Memorial Sloan-Kettering Cancer Center; 2012. Available from: https://
webcore.mskcc.org/breastq/qscore/qscore-manual.pdf.
16. Cano SK, Klassen AF, Scott AM, et al. The BREAST-Q: further validation in
independent clinical samples. Plast Reconstr Surg. 2012;129:293Y302.
17. Cano SJ, Klassen AF, Scot AM, et al. A closer look at the BREAST-Q. Clin
Plast Surg. 2013;40:287Y296.
Annals of Plastic Surgery &Volume 76, Number 6, June 2016 Breast Reconstruction Post Mastectomy
*2014 Wolters Kluwer Health, Inc. All rights reserved. www.annalsplasticsurgery.com 643
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
18. Panjari M, Robin JB, Davis SR. Sexual function after breast cancer. J Sex Med.
2011;8:294Y302.
19. Bell RJ, Robinson PJ, Fradkin P, et al. Breast reconstruction following mas-
tectomy for invasive breast cancer is strongly influenced by demographic
factors in women in Victoria, Australia. Breast. 2012;21:394Y400.
20. Morrow M, Pusic A. Time for a new era in outcomes reporting for breast re-
construction. J Natl Cancer Inst. 2011;103:5Y7.
21. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-
related quality of life: the remarkable universality of half a standard devia-
tion. Med Care. 2003;41:582Y592.
22. D’Souza N, Darmanin G, Fedorowicz Z. Immediate versus delayed recon-
struction following surgery for breast cancer. Cochrane Database Syst Rev.
2011:1Y26.
23. Alderman AK, Wilkins EF, Lowery JC, et al. Determinants of patient satis-
faction in post-mastectomy breast reconstruction. Plast Reconstr Surg.
2000;106:769Y776.
24. Clough KB, O’Donoghue JM, Fitoussi AD, et al. Prospective evaluation of late
cosmetic results following breast reconstruction II TRAM flap reconstruction.
Plast Reconstr Surg. 2001;107:1710Y1716.
25. Damen TH, de Bekker-Grob EW, Mureau MA, et al. Patients’ preference for
breast reconstruction: a discrete choice experiment. J Plast Reconstr Aesthet
Surg. 2011;64:75Y83.
26. Damen THC, Timman R, Kunst HH, et al. High satisfaction rates in women after
DIEP flap breast reconstruction. J Plast ReconstrAesthet Surg.2010;63:93Y100.
27. Hall SE, Holman CD. Inequalities in breast cancer reconstructive surgery
according to social and locational status in Western Australia. Eur J Surg
Oncol. 2003;29:519Y525.
28. Reaby LL. Reasons why women who havemastectomy decide to have or not to
have breast reconstruction. Plast Reconstr Surg. 1998;101:1810Y1818.
29. Crompvoets S. Comfort, control or conformity: women who choose breast re-
construction following mastectomy. Health Care Women Int.2006;27:75Y93.
30. Singletary SE. Skin sparing mastectomy with immediate breast reconstruction:
the MD Anderson Cancer Center experience. Ann Surg Oncol.1996;4:411Y416.
31. Noone RB, Frazier TG, Noone GC, et al. Recurrence of breast carcinoma
following immediate reconstruction: a 13-year review. Plast Reconstr Surg.
1994;93:96Y106.
32. Johnson CH, van Heerden JA, Donohue JH, et al. Oncological aspects of
immediate breast reconstruction following mastectomy for malignancy. Arch
Surg. 1989;124:819Y823.
Ng et al Annals of Plastic Surgery &Volume 76, Number 6, June 2016
644 www.annalsplasticsurgery.com *2014 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
... Recently, the emphasis on utilizing patient-reported outcomes to evaluate the postoperative quality of life of patients with breast cancer as well as the emphasis on considering local recurrence and survival rates have increased [4,5]. Although studies have compared mastectomy with and without breast reconstruction [6][7][8][9][10][11][12], few studies have compared BCT, mastectomy alone, and mastectomy with breast reconstruction. Therefore, we conducted a cross-sectional survey using the BREAST-Q questionnaire, which is a wellestablished tool used to measure patient-reported outcomes. ...
... Rights reserved. [6][7][8][9][10][11][12]. These findings are consistent with the results of this study. ...
Article
Full-text available
Purpose Breast-conserving surgery is the preferred treatment for breast cancer; however, its associated risk of local recurrence is higher than that of mastectomy. We performed a comparative analysis of four patient-reported outcomes, psychosocial well-being, sexual well-being, breast satisfaction, and physical well-being of the chest, and quality of life after three surgical approaches, breast-conserving therapy (BCT), mastectomy alone, and mastectomy with breast reconstruction, for breast cancer treatment. Methods A cross-sectional survey using the BREAST-Q questionnaire and including patients who had undergone breast surgery at least 1 year prior to survey completion was performed. The analysis included 1035 patients (mean age, 55.0 ± 9.1 years) who underwent breast reconstruction, 116 patients (mean age, 63.6 ± 12.2 years) who underwent mastectomy, and 64 patients (mean age, 60.8 ± 12.2 years) who underwent BCT. Results Patients who underwent reconstruction had significantly higher psychosocial well-being scores (62.8 ± 18.4) than those who underwent BCT (57.0 ± 23.6) and mastectomy (50.8 ± 16.8) (p < 0.01). However, significant differences in self-acceptance scores among all patients were not observed. Regarding sexual well-being and breast satisfaction, patients who underwent mastectomy had significantly lower scores (29.9 ± 18.7 and 41.8 ± 17.7, respectively) than those who underwent BCT (45.8 ± 26.6 and 58.3 ± 17.5, respectively) and reconstruction (46.4 ± 20.3 and 58.8 ± 15.4, respectively) (p < 0.01). Physical well-being of the chest scores were not significantly different among all patients (p = 0.14). Symptoms after mastectomy included chest muscle pain and arm movement impairment. Breast pain was a notable symptom after BCT. Conclusion The study findings provide valuable insights regarding patient-reported outcomes, highlight the potential benefits of breast reconstruction, and emphasize the importance of patients’ preferences.
... With the advancement of medicine and healthcare, new protocols and techniques were utilized to detect BC as soon as possible to prevent metastasis, increase the five-year survival rate, and preserve the aesthetic appearance [4]. A study was conducted in Australia using the BREAST-Q questionnaire to measure satisfaction post-mastectomy [5]. The results found that satisfaction was significantly higher in the reconstructed group in comparison to the non-reconstructed group, in which the main reason for seeking the reconstruction was to improve their self-image [6]. ...
... While the majority of participants in the study reported being satisfied with the outcome after mastectomy, it is important to recognize that many of them still struggled with a range of psychological, social, and emotional challenges during their treatment [5,6]. Mastectomy is a major surgery that can overwhelmingly impact patients' lives [6,7]. ...
Article
Full-text available
Background Overall well-being after surgical intervention is one of the most important aspects of assessing quality of life (QOL), yet it is not well explored in the literature. In this paper, it was necessary to involve the patient's perspective of the nature of their QOL. The burden of being diagnosed with breast cancer is an adaptation to a new lifestyle, having to deal with disease stigma, interpersonal relations problems, and being limited to specific clothing. This can be very challenging for patients. This study aims to identify which patient group, based on their treatment regimen, exhibits higher levels of satisfaction and dissatisfaction compared to other groups. Methods A retrospective, cross-sectional study analyzing the QOL among female breast cancer patients who underwent mastectomy, with or without breast reconstruction, in King Abdulaziz Medical City, Jeddah, between 2009 and 2022. Patients' demographics and phone numbers were obtained from each patient's medical record file in our hospital. Phone call-based interviews were conducted to contact patients to assess their QOL, satisfaction, and regrets after surgery. We excluded patients who do not speak Arabic, are illiterate, have memory disorders, patients who underwent lumpectomy or palliative mastectomy, patients with metastatic stage 4 cancer at the time of diagnosis, patients who are males, and patients who passed away. Results A total of 2,309 patients were screened during the period aforementioned; a total of 346 patients met our inclusion criteria. All of whom are female participants with a current mean age of 52.3 ± 11.5 years. There were 301 (86.99%) participants reported being satisfied, while only 45 (13.01%) participants reported being unsatisfied with surgery outcomes. Although the majority of participants were satisfied after mastectomy, many of them still struggled with psychological, social, and/or emotional challenges. These challenges can have a significant impact on a patient's overall well-being and QOL and must be addressed to provide patients with the highest quality of care possible. Conclusion The study findings highlight the significant impact of mastectomy on patients' lives. It is important to consider individual patient experiences and circumstances when evaluating treatment outcomes and patient satisfaction. We observed that patient satisfaction may vary depending on several factors, including patients' baseline satisfaction. Those factors may be psychological, such as body image issues, low self-esteem, the feeling of losing a body part, and fear of recurrence or metastasis. Other factors may be postoperative-related complications, including lymphedema, redundant skin, chronic pain, and operation scar. Additionally, factors may be socially related, such as loss of confidence, social withdrawal, embarrassment, inability to buy prostheses, being limited to specific clothes, and occupational impact.
... This is partly attributable to legislation passed in 1998 ensuring insurance coverage for all stages of mastectomy-related reconstruction and partly due to technical advances and the now-recognized benefits for overall patient well-being 2) . For many, breasts are an important component of self-image, and individuals who undergo reconstruction after mastectomy report significantly higher overall satisfaction with their psychological and sexual well-being 3) . ...
Article
Full-text available
Objectives: Comorbidities that impair wound healing, increase infection risk, and compromise tissue viability influence rates of hospital readmission after autologous reconstruction and implant-based reconstruction. This study aimed to evaluate patient factors that increase risk for 30-day hospital readmission after autologous reconstruction and implant-based reconstruction and identify differences in the comorbidities that affect readmission risk after each method. Methods: Patients from 2005 to 2021 were selected by autologous reconstruction and implant-based reconstruction current procedural terminology codes from the American College of Surgeons National Surgical Quality Improvement Program database. A multivariable regression model identified the significant predictors of unplanned readmission. Results: Comorbidities that increase risk for readmission after autologous reconstruction but not implant-based reconstruction include dialysis (OR 3.87, p = 0.042) and malnutrition (OR 3.20, p = 0.003). Risk factors for readmission after implant-based reconstruction but not autologous reconstruction include bleeding disorder (OR 2.62, p < 0.0001), previous infection (OR 1.49, p = 0.045), recent sepsis (OR 2.16 p = 0.0003), anemia (OR 1.13, p = 0.0018), and hypoalbuminemia (OR 1.35, p = 0.0213). Predictors of unplanned readmission after both methods include chronic obstructive pulmonary disorder, obesity, inpatient status prior to procedure, Black or White race, chronic steroid use, smoking, diabetes, and hypertension. Conclusions: These findings may be used to individualize preoperative discussions and help guide optimization of risk factors. In addition, while autologous reconstruction and implant-based reconstruction are often combined into one category for discussion of factors that increase complication risk, our study suggests that the types of reconstruction differ with regard to the comorbidities that increase risk for hospital readmission.
Article
African Americans have a long history of disparities in healthcare. However, whether their racial disparity exists in breast reconstruction outcomes is less clear. This study compared short-term outcomes of African Americans and Caucasians who underwent autologous (ABR) and implant-based breast reconstruction (IBR). Patients having ABR or IBR were identified in the National Inpatient Sample from Q4 2015–2020. Multivariable logistic regressions were used to compare in-hospital outcomes between African Americans and Caucasians, adjusted for demographics, socioeconomic status, comorbidities, and hospital characteristics. In ABR, there were 8296 (63.89%) Caucasians and 1809 (13.93%) African Americans. In IBR, there were 12,258 (68.24%) Caucasians and 1847 (10.28%) African Americans. During the same period, 32,406 (64.87%) Caucasians and 7702 (15.42%) African Americans underwent mastectomy, indicating a lower reconstruction rate in African Americans, particularly in IBR. African Americans presented with significant preoperative differences, including younger age, higher comorbid burden, and pronounced socioeconomic disadvantages. After accounting for preoperative differences, in ABR, African Americans had higher renal complications (aOR = 1.575, 95 CI = 1.024–2.423, p = 0.04) hemorrhage/hematoma (aOR = 1.355, 95 CI = 1.169–1.571, p < 0.01), and transfer rate (aOR = 2.176, 95 CI = 1.257–3.768, p = 0.01). In IBR, African Americans had higher superficial wound complications (aOR = 1.303, 95 CI = 1.01–1.681, p = 0.04), flap revision (aOR = 4.19, 95 CI = 1.229–14.283, p = 0.02), and hemorrhage/hematoma (aOR = 1.791, 95 CI = 1.401–2.291, p < 0.01). In both ABR and IBR, African Americans had longer hospital length of stay (p < 0.01). These results highlight evident racial disparities in breast reconstruction for African Americans. Targeted interventions are needed to guarantee equitable access to breast reconstruction services and to address postoperative complications in African Americans.
Chapter
Although 3D printing is not as extensively used in breast radiology as compared to other surgical specialties, it is a useful modality in the surgeons’ armamentarium. It can be used to improve breast mass localization and thus aids in breast conservation surgery in cases with more extensive disease. Implants used for breast reconstruction can be optimized. Further flap harvesting and volume calculation is also improved. 3D printed models aid in patient education and communication. This chapter explores the existing use and future directions of medical 3D printing in breast cancer surgery.
Article
Introduction: Autologous fat grafting is a method of improving aesthetic outcomes after both breast reconstruction and aesthetic surgery through volume enhancement and tissue contouring. Long-lasting effects are linked to greater patient satisfaction and more optimal augmentation results. Harvesting, processing, and injection techniques may all affect the longevity of deformity filling. Our objective is to evaluate the effect of lipoaspirate processing modality on longitudinal volume retention after surgery. Methods: A prospective, single-institution, randomized control trial placed consented postmastectomy fat grafting patients into 1 of 3 treatment arms (active filtration, low-pressure decantation, and standard decantation) in a 1:1:1 ratio. A preoperative 3-dimensional scan of the upper torso was taken as baseline. At the 3-month postoperative visit, another 3D scan was taken. Audodesk Meshmixer was used to evaluate the volume change. Results: The volume of fat injected during the initial procedure did not differ significantly between the treatment arms (P > 0.05). Both active filtration and low-pressure decantation resulted in higher percentage volume retention than traditional decantation (P < 0.05). Active filtration and low-pressure decantation exhibited comparable degrees of fat maintenance at 3 months (P > 0.05). Discussion: Compared with using traditional decantation as the lipoaspirate purification technique, active filtration and low-pressure decantation may have led to higher levels of cell viability by way of reduced cellular debris and other inflammatory components that may contribute to tissue resorption and necrosis. Further immunohistochemistry studies are needed to examine whether active filtration and low-pressure decantation lead to lipoaspirates with more concentrated viable adipocytes, progenitor cells, and factors for angiogenesis.
Article
Introduction Disparities in postmastectomy reconstructive care are widely acknowledged. However, there is limited understanding regarding the impact of reconstructive services on cancer recurrence and breast cancer–related mortality. Therefore, this study aims to examine how patient-specific factors and breast reconstruction status influence recurrence-free survival and mortality rates in breast cancer patients. Methods Retrospective chart review was performed to collect data on patients who underwent mastectomy at 2 institutions within the New York-Presbyterian system from 1979 to 2019. Sociodemographic information, medical history, and the treatment approach were recorded. Propensity score matching, logistic regression, unpaired t test, and chi-square test were used for statistical analysis. Results Overall, cancer recurrence occurred in 6.62% (317) of patients, with 16.8% (803) overall mortality rate. For patients who had relapsed disease, completion of the reconstruction sequence was correlated with an earlier detection of cancer recurrence and improved survival odds ( P < 0.05). Stratified analysis of the reconstruction group alone showed mortality benefit among patients who underwent free flap procedures ( P < 0.05). Conclusion Patients undergoing breast reconstruction after mastectomy are likely to have better access to follow-up care and improved interfacing with the healthcare system. This may increase the speed at which cancer recurrence is detected. This study highlights the need for consistent plastic surgery referral and continued monitoring by all members of the breast cancer care team for cancer recurrence among patients.
Article
Background Chronic obstructive pulmonary disease (COPD) is a common comorbid condition that can be associated with postoperative mortality and morbidity. However, the outcome profile of patients with COPD after breast reconstruction has yet to be established. Therefore, this study aimed to assess the postoperative outcomes in patients with COPD who underwent autologous (ABR) and implant‐based breast reconstruction (IBR). Methods National Inpatient Sample was used to identify patients who underwent ABR or IBR from Q4 2015 to 2020. Multivariable logistic regressions were used to compare inhospital outcomes between COPD and non‐COPD patients while adjusting for demographics, primary payer status, hospital characteristics, and comorbidities. Results There were 1288 (9.92%) COPD and 11,696 non‐COPD patients who underwent ABR. Meanwhile, 1742 (9.70%) COPD and 16,221 non‐COPD patients underwent IBR. In both ABR and IBR, patients with COPD had higher rates of seroma (ABR, aOR = 1.863, 95% CI = 1.022–3.397, and p = 0.04; IBR, aOR = 1.524, 95% CI = 1.014–2.291, and p = 0.04), infection (ABR, aOR = 1.863, 95% CI = 1.022–3.397, and p = 0.04; IBR, aOR = 1.956, 95% CI = 1.205–3.176, and p = 0.01), and prolonged LOS ( p < 0.01). Specifically, patients with COPD in ABR had higher risks of respiratory complications (aOR = 1.991, 95% CI = 1.291–3.071, and p < 0.01) and incurred higher total hospital charges ( p < 0.01). Meanwhile, patients with COPD undergoing IBR had elevated risks of renal complications (aOR = 3.421, 95% CI = 2.108–5.55, and p < 0.01), deep wound complications (aOR = 3.191, 95% CI = 1.423–7.153, and p < 0.01), and a higher rate of transfers out (aOR = 1.815, 95% CI = 1.081–3.05, and p = 0.02). Conclusion COPD is an independent risk factor associated with distinct adverse outcomes in ABR and IBR. These findings can be valuable for preoperative risk stratification, determining surgical candidacy, and planning postoperative management in patients with COPD.
Article
Background There has been a greater focus in recent literature proposing air to be a superior medium to saline in tissue expanders. This study aims to review the literature and assess the quality of data on the efficacy and safety of air as an alternative medium to saline in tissue expanders, in the setting of postmastectomy two-stage reconstruction. Methods A systematic review regarding air inflation of tissue expanders was conducted using PubMed, Embase, Cochrane Library, and Web of Science. The methods followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Three reviewers separately performed data extraction and comprehensive synthesis. Results A total of 427 articles were identified in our search query, of which 11 met the inclusion criteria. Three pertained to inflation with room air, and eight pertained to inflation with CO2 using the AeroForm device. They were comparable to decreased overall complication rates in the room air/CO2 cohort compared to saline, although statistical significance was only observed in one of five two-arm studies. Investigating specific complications in the five two-arm studies, significantly lower rates of skin flap necrosis were only observed in two CO2-based studies. Studies rarely discussed other safety profile concerns, such as the impacts of air travel, radiation planning, and air extravasation beyond descriptions of select patients within the cohort. Conclusion There is insufficient evidence to suggest improved outcomes with room air inflation of tissue expanders. Further work is needed to fully characterize the benefits and safety profiles of air insufflation before being adopted into clinical practice.
Article
Full-text available
This study explored factors associated with the likelihood of reconstruction after unilateral mastectomy and the wellbeing of women after reconstruction. Data were from a questionnaire completed on average 1.8 years after diagnosis by 1429 women in the BUPA Health and Wellbeing After Breast Cancer Study. Logistic regression was used to model factors associated with reconstruction. The Psychological General Wellbeing Questionnaire was used to assess wellbeing. A total of 25.4% of 366 women who had a unilateral mastectomy had undergone a reconstruction nearly two years after diagnosis. Being younger (p<0.001), educated beyond school (p<0.04), living in the metropolitan area (p<0.001), having private health insurance (p=0.003), not having dependent children (p=0.004) and not having radiotherapy (p<0.001) explained just over 40% of the variation in reconstruction status. There was a modest difference between women who did and did not have a reconstruction in terms of wellbeing. Demographic factors strongly influence the likelihood of reconstruction after mastectomy.
Article
Full-text available
Background: Breast cancer is the most prevalent cancer in women and has a lifetime incidence of one in nine in the UK. Curative treatment requires surgery, and may involve adjuvant and neo-adjuvant therapy. In many women, post-mastectomy breast reconstruction is essential to restore body image and improve quality of life. Timing of reconstruction may be immediately at the time of mastectomy or delayed until after surgery. Outcomes such as psychosocial morbidity, aesthetics and complications rates may differ between the two approaches. Objectives: To assess the effects of immediate versus delayed reconstruction following surgery for breast cancer. Search strategy: We searched the Cochrane Breast Cancer Group (CBCG) Specialised Register on 22 July 2010, MEDLINE from July 2008 to 26 August 2010, EMBASE from 2008 to 26 August 2010 and the WHO International Clinical Trials Registry Platform (ICTRP) on 26 August 2010. Selection criteria: Randomised controlled trials (RCTs) comparing immediate breast reconstruction versus delayed or no reconstruction in women in any age group and stage of breast cancer. We considered any recognised methods of reconstruction to one or both breasts undertaken at the same time as mastectomy or at any time following mastectomy. Data collection and analysis: Two review authors independently screened papers, extracted trial details and assessed the risk of bias in the one eligible study. Main results: We included only one RCT that involved that involved 64 women.We judged this study as being at a high risk of bias. Post-operative morbidity and mortality were not addressed, and secondary outcomes of patient cosmetic evaluations and psychosocial well-being post-reconstruction were inadequately reported. Based on limited data there was some, albeit unreliable, evidence that immediate reconstruction compared with delayed or no reconstruction, reduced psychiatric morbidity reported three months post-operatively. Authors' conclusions: The current level of evidence for the effectiveness of immediate versus delayed reconstruction following surgery for breast cancer was based on a single RCT with methodological flaws and a high risk of bias, which does not allow confident decision-making about choice between these surgical options. Until high quality evidence is available, clinicians may wish to consider the recommendations of relevant guidelines and protocols. Although the limitations and ethical constraints of conducting RCTs in this field are recognised, adequately powered controlled trials with a focus on clinical and psychological outcomes are still required. Given the paucity of RCTs in this subject, in future versions of this review we will look at study designs other than RCTs specifically good quality cohort and case-controlstudies.
Article
The BREAST-Q(©) is a multiscale, multimodule, patient-reported outcome instrument (PRO) measuring health-related quality of life and patient satisfaction in women who undergo breast surgery. This PRO instrument is the flagship of our team's research, which has spanned almost a decade. This article provides detail about the BREAST-Q(©). The BREAST-Q(©) represents a significant advance in measuring the impact and effectiveness of breast surgery from the patients' perspective. In addition, our overall approach may provide a useful template for the development of future PRO instruments.
Article
Background Sexual dysfunction is a medical condition that can lead to relationship issues as well as depression and has a somatoform basis. It is estimated to affect 49 % of Brazilian women. Studies have shown that both cancer diagnosis and its surgical treatment (mastectomy) affect women psychologically and can lead to psychiatric disorders. The aim of this study was to evaluate and compare sexuality in women who underwent mastectomy alone with those who underwent breast reconstruction after mastectomy. Method This descriptive transversal study analyzed two groups of patients, one with 17 women after mastectomy alone and another with 19 women who underwent breast reconstruction post mastectomy. The patients ranged in age from 18 to 60 years old. The exclusion criteria were illiteracy; ongoing chemotherapy, radiotherapy, or psychiatric treatment; or if any surgery had been performed the previous year. All patients were from the Gynecology and Plastic Surgery Department of the Federal University of São Paulo. They voluntarily answered the FSFI (Female Sexual Function Index) questionnaire. Statistical analyses were performed using Student’s t test and Pearson’s coefficient, and the significance level used was p < 0.05. Results Data showed a lower FSFI score for the mastectomy-alone group compared to the breast reconstruction group (median = 10.15 ± 2.636 and 22.44 ± 3.055, respectively; p = 0.0057). There was no relationship established between the scores and postoperative time (post, p = 0.9382; pre, p = 0.2142) or between scores and remuneration income (post, p = 0.7699; pre, p = 0.5245), stable relationship (post, p = 0.2613; pre, p = 0.5245), and age (post, p = 0.3951; pre, p = 0.8427) for both groups. Mean age has shown no significant difference (p = 0.4740; median post = 47.71 ± 2.012; medina pre = 46.69 ± 1.809). Conclusion An improvement in sexual function has been observed in patients who underwent breast reconstruction after mastectomy, probably as a result of better self-esteem as well as body image, both of which are affected by a mastectomy. The aesthetic results were evaluated using a questionnaire, and all the patients answered positively. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www. springer. com/ 00266.
Article
: Despite its benefits in body image, self-esteem, sexuality, and quality of life, historically fewer than 25 percent of patients undergo immediate breast reconstruction. After passage of the Women Health and Cancer Rights Act, studies failed to demonstrate changes in reconstructive rates. A recent single-year report suggests significant shifts in U.S. breast reconstruction patterns. The authors' goal was to assess long-term trends in rates and types of immediate reconstruction. : A serial cross-sectional study of immediate breast reconstruction trends was performed using the Nationwide Inpatient Sample database from 1998 to 2008. Data on mastectomies, reconstructive method (autologous/implant), and sociodemographic/hospital predictors were obtained. : Immediate breast reconstruction rates increased on average 5 percent per year, from 20.8 percent to 37.8 percent (p < 0.01). Autologous reconstruction rates were unchanged. Implant use increased by an average of 11 percent per year (p < 0.01), surpassing autologous methods as the leading reconstructive modality after 2002. The strongest predictors of implant use were procedures performed after 2002, bilateral mastectomies, patients operated on in Midwest/West regions, and Medicare recipients. In contrast to bilateral mastectomies, which increased by 17 percent per year (p < 0.01), unilateral mastectomies decreased by 2 percent per year (p < 0.01). Bilateral mastectomy defects had significantly higher reconstruction rates than unilateral counterparts (p < 0.01). : The significant rise in immediate reconstruction rates in the United States correlates closely to a 203 percent expansion in implant use. Although the reason for the increase in implant use is multifactorial, changes in mastectomy patterns, such as increased use of bilateral mastectomies, are one important contributor.
Article
The BREAST-Q is a new patient-reported outcome instrument for cosmetic and reconstructive breast surgery. For it to be used appropriately in clinical research, it is important that its validity is demonstrated. The aim of this study was to test this property. The authors evaluated the BREAST-Q subscales by using Rasch measurement methods and traditional psychometric methods with a focus on construct validity (including comparisons with existing breast-related, patient-reported outcome measures) and clinical validity (including hypothesis-driven questions with clinical subsamples). A total of 817 women returned completed questionnaires (corrected response rate, 66 percent). Validity was supported by three Rasch analysis findings: the number of item response options was found to be appropriate (thresholds were ordered correctly); item locations in each subscale were spread out (range of logit span, 0.7 to 6.6), indicating that each subscale captures a wide range of issues; and fit to the Rasch model was good. Overall, scale reliability was supported by high Person separation indices (≥0.73). Traditional psychometric scale validity was supported by interscale correlations, comparisons of scores generated from clinically defined subgroups, and correlations with sociodemographic variables. Scale reliability was supported by high Cronbach's alpha coefficients (>0.80), item-total correlations (range of means, 0.58 to 0.87), and intraclass correlation coefficients (>0.80). This study further supports the BREAST-Q as a useful tool to study the impact and effectiveness of breast surgery from the patients' perspective. It can be used as the initial building blocks toward establishing the clinical meaning of BREAST-Q scale scores, further supporting an evidence-based approach to surgical practice.
Article
To prospectively evaluate the psychosocial outcomes and body image of patients 2 years postmastectomy reconstruction using a multicenter, multisurgeon approach. Although breast reconstruction has been shown to confer significant psychosocial benefits in breast cancer patients at year 1 postreconstruction, we considered the possibility that psychosocial outcomes may remain in a state of flux for years after surgery. Patients were recruited as part of the Michigan Breast Reconstruction Outcome Study, a 12 center, 23 surgeon prospective cohort study of mastectomy reconstruction patients. Two-sided paired sample t tests were used to compare change scores for the various psychosocial subscales. Multiple regression analysis was used to determine whether the magnitude of the change score varied by procedure type. Preoperative and postoperative year 2 surveys were received from 173 patients; 116 with immediate and 57 with delayed reconstruction. For the immediate reconstruction cohort, significant improvements were observed in all psychosocial subscales except for body image. This occurred essentially independent of procedure type. In the cohort with delayed reconstruction, significant change scores were observed only in body image. Women with transverse rectus abdominis musculocutaneous flaps had significantly greater gains in body image scores (P = 0.003 and P = 0.034, respectively) when compared with expander/implants. General psychosocial benefits and body image gains continued to manifest at 2 years postmastectomy reconstruction. In addition, procedure type had a surprisingly limited effect on psychosocial well being. With outcomes evolving beyond year 1, these data support the need for additional longitudinal breast reconstruction outcome studies.
Article
Breast cancer (BC) remains the most common non-skin cancer in women and an increasing number are living as BC survivors. The aim of this article is to evaluate the impact of the first diagnosis of invasive BC and its treatment, menopausal symptoms, and body image on sexual function. The BUPA Foundation Health and Wellbeing after Breast Cancer Study is a prospective cohort study of 1,684 women recruited within 12 months of their first diagnosis with invasive BC. Each participant completed an enrollment questionnaire (EQ) and first follow-up questionnaire (FQ1) 12 months post-EQ. Sexual function was evaluated by the Menopause-Specific Quality of Life Questionnaire embedded within the FQ1. Of the 1,011 women in the analyses, 70% experienced sexual function problems and 77% reported vasomotor symptoms. Women experiencing sexual function problems were postmenopausal (P = 0.02), experienced vasomotor symptoms (P < 0.01), and used aromatase inhibitors (P = 0.03). Women with vasomotor symptoms were twice as likely to experience sexual function problems (odds ratio [OR] 1.93, 95% confidence interval [CI] 141, 2.63; P < 0.001). This association was more extreme for women on aromatase inhibitors (OR 3.49, 95% CI 1.72, 7.09; P = 0.001) but did not persist in women not using endocrine therapies (OR 1.41, 95% CI 0.84, 2.36; P = 0.19). Women on aromatase inhibitors were more likely to report sexual function problems (OR 1.50, 95% CI 1.0, 2.2, P = 0.04) and women with body image issues were 2.5 times more likely to report sexual function problems (OR 2.5 95% CI 1.6, 3.7, P < 0.001). Women using tamoxifen were not more likely to experience sexual function problems (OR 1.1, 95% CI 0.8, 1.5, P = 0.6); however, women with body image issues were twice as likely to experience sexual function problems (OR 2.1, 95% CI 1.5, 3.0, P < 0.001). Seventy percent of partnered BC survivors less than 70 experienced sexual function problems. Sexual problems are related to the use of aromatase inhibitors which can exacerbate menopausal symptoms.